Trials / Completed
CompletedNCT06482099
SPECIAL INVESTIGATION FOR ABRYSVO IN PREGNANT WOMEN AND INFANTS
Special Investigation for ABRYSVO Intramuscular Injection -Investigation in Pregnant Women and Infants-
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 497 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 0 Years
- Healthy volunteers
- Accepted
Summary
This post-marketing study is a multicenter cohort study in pregnant women vaccinated with Abrysvo (RSV vaccine）designed to confirm the safety in pregnant women and their infants under actual clinical practice in Japan.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | RSVpreF vaccine | Injection in the muscle, 1 dose 0.5mL |
Timeline
- Start date
- 2024-10-01
- Primary completion
- 2026-02-27
- Completion
- 2026-02-27
- First posted
- 2024-07-01
- Last updated
- 2026-04-09
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT06482099. Inclusion in this directory is not an endorsement.